Aurobindo Pharma’s stepdown subsidiary, Eugia Steriles Private Ltd, has received its first product approval from the US FDA for Lidocaine Hydrochloride injection. The approval came after an inspection of their new injectables manufacturing facility in Andhra Pradesh. This achievement is pivotal for Aurobindo Pharma’s expansion plans.
Related Posts
Nvidia set to replace Intel in Dow Jones index
Nvidia is set to replace Intel in the Dow Jones Industrial Average, marking a significant change influenced by Nvidia’s substantial 900% growth over the last […]
Ford may look at LCVs in India
Ford is planning a return to India by exploring the light commercial vehicle and pick-up segment, including both internal combustion and electric options. The company […]